Victory Capital Management Inc Cullinan Oncology, Inc. Transaction History

Victory Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$11.82 - $15.42 $496,203 - $647,331	41,980 New	41,980 $538,000
Q2 2022 Aug 01, 2022	SELL	$7.31 - $13.55 $218,788 - $405,551	-29,930 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$10.47 - $16.75 $9,318 - $14,907	-890 Reduced 2.89%	29,930 $313,000
Q4 2021 Feb 07, 2022	SELL	$15.36 - $25.0 $21,964 - $35,750	-1,430 Reduced 4.43%	30,820 $476,000
Q3 2021 Nov 02, 2021	SELL	$22.56 - $29.68 $6,091 - $8,013	-270 Reduced 0.83%	32,250 $728,000
Q2 2021 Aug 03, 2021	SELL	$24.96 - $41.25 $53,664 - $88,687	-2,150 Reduced 6.2%	32,520 $837,000
Q1 2021 May 04, 2021	BUY	$28.0 - $53.42 $970,760 - $1.85 Million	34,670 New	34,670 $1.45 Million

146

67.6M

612K

118K

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $499M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.